NEpiC: A network-assisted algorithm for epigenetic studies using mean and variance combined signals

Nucleic Acids Research

Volumn 44, Issue 16, 2016, Pages

  Ruan, Peifeng ^a   Shen, Jing ^b   Santella, Regina M ^b   Zhou, Shuigeng ^a   Wang, Shuang ^b  

^a FUDAN UNIVERSITY   (China)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; DNA METHYLATION; EPIGENETICS; GENETIC ALGORITHM; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LIVER CELL CARCINOMA; NEPIC ALGORITHM; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUALITY CONTROL; SCORING SYSTEM; SIMULATION; ALGORITHM; BREAST TUMOR; COMPUTER SIMULATION; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETICS; TUMOR INVASION;

ALGORITHMS; BREAST NEOPLASMS; COMPUTER SIMULATION; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASM INVASIVENESS;

EID: 84988968777     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw546     Document Type: Article

References (67)

1. Tischoff, I. and Tannapfel, A. (2008). DNA methylation in hepatocellular carcinoma. World J. Gastroenterol.: WJG., 14, 1741-1748.
2. Sato, Y., Yoshizato, T., Shiraishi, Y., Maekawa, S., Okuno, Y., Kamura, T., Shimamura, T., Sato-Otsubo, A., Nagae, G., Suzuki, H. et al. (2013). Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet., 45, 860-867.
3. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J.G., Baylin, S.B. and Issa, J.P.J. (1999). CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A., 96, 8681-8686.
4. Tao, M.H. and Freudenheim, J.L. (2010). DNA methylation in endometrial cancer. Epigenetics, 5, 491-498
5. Eden, A., Gaudet, F., Waghmare, A. and Jaenisch, R. (2003). Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455-455.
6. Ruike, Y., Imanaka, Y., Sato, F., Shimizu, K. and Tsujimoto, G. (2010). Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics, 11, 137.
7. Ammerpohl, O., Pratschke, J., Schafmayer, C., Haake, A., Faber, W., von Kampen, O., Balschun, K., Rocken, C., Arlt, A., Schniewind, B. et al. (2012). Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer, 130, 1319-1328.
8. Shen, J., Wang, S., Zhang, Y.J., Wu, H.C., Kibriya, M.G., Jasmine, F., Ahsan, H., Wu, D.P., Siegel, A.B., Remotti, H., et al. (2013). Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics, 8, 34-43.
9. Sun, H. and Wang, S. (2012). Penalized logistic regression for high-dimensional DNA methylation data with case-control studies. Bioinformatics, 28, 1368-1375.
10. Sun, H. and Wang, S. (2013). Network-based regularization for matched case-control analysis of high-dimensional DNA methylation data. Stat. Med., 32, 2127-2139.
11. Wang, K., Li, M. and Bucan, M. (2007). Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet., 81, 1278-1283.
12. Chen, M., Cho, J. and Zhao, H. (2011). Incorporating biological pathways via a Markov random field model in genome-wide association studies. PLoS Genet., 7, e1001353.
13. Jia, P., Zheng, S., Long, J., Zheng, W. and Zhao, Z. (2011). dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics, 27, 95-102.
14. Baranzini, S.E., Galwey, N.W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B., Kappos, L., Polman, C.H., et al. (2009). Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet., 18, 2078-2090.
15. Rossin, E.J., Lage, K., Raychaudhuri, S., Xavier, R.J., Tatar, D., Benita, Y., Cotsapas, C. and Daly, M.J. (2011). Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet., 7, e1001273.
16. West, J., Beck, S., Wang, X. and Teschendorff, A.E. (2013). An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathways. Sci. Rep., 3, 1630.
17. Jiao, Y., Widschwendter, M. and Teschendorff, A.E. (2014). A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control. Bioinformatics, 30, 2360-2366.
18. Hansen, K.D., Timp, W., Bravo, H.C., Sabunciyan, S., Langmead, B., McDonald, O.G., Wen, B., Liu, Y., Diep, D., Briem, E., et al. (2011). Increased methylation variation in epigenetic domains across cancer types. Nat. Genet., 43, 768-775.
19. Teschendorff, A.E. and Widschwendter, M. (2012). Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics, 28, 1487-1494.
20. Teschendorff, A.E., Liu, X., Caren, H., Pollard, S.M., Beck, S., Widschwendter, M. and Chen, L. (2014). The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput. Biol., 10, e1003709.
21. Chen, Y., Ning, Y., Hong, C. andWang, S. (2014). Semiparametric Tests for Identifying Differentially Methylated Loci With Case-Control Designs Using Illumina Arrays. Genet. Epidemiol., 38, 42-50.
22. Morgan, W.A. (1939). A test for the significance of the difference between two variances in a sample from a normal bivariate population. Biometrika, 31, 13-19.
23. Pitman, E.J.G. (1939). A note on normal correlation. Biometrika, 31, 9-12.
24. Wu, J., Vallenius, T., Ovaska, K., Westermarck, J., Makela, T.P. and Hautaniemi, S. (2009). Integrated network analysis platform for protein-protein interactions. Nat. Methods, 6, 75-77.
25. Shibata, T. and Aburatani, H. (2014). Exploration of liver cancer genomes. Nat. Rev. Gastroenterol. Hepatol., 11, 340-349.
26. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004). A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183.
27. Pidsley, R., Wong, C.C., Volta, M., Lunnon, K., Mill, J. and Schalkwyk, L.C. (2013). A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics, 14, 293.
28. Ongenaert, M., Van Neste, L., De Meyer, T., Menschaert, G., Bekaert, S. and Van Criekinge, W. (2008). PubMeth: a cancer methylation database combining text-mining and expert annotation. Nucleic Acids Res., 36, D842-D846.
29. Zhang, B., Kirov, S. and Snoddy, J. (2005). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res., 33, W741-W748.
30. Rodriguez, J., Munoz, M., Vives, L., Frangou, C.G., Groudine, M. and Peinado, M.A. (2008). Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc. Natl. Acad. Sci. U.S.A., 105, 19809-19814.
31. Fackler, M.J., Umbricht, C.B., Williams, D., Argani, P., Cruz, L.A., Merino, V.F., Teo, W.W., Zhang, Z., Huang, P., Visvananthan, K., et al. (2011). Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res., 71, 6195-6207.
32. Kumar, R., Manning, J., Spendlove, H.E., Kremmidiotis, G., McKirdy, R., Lee, J., Millband, D.N., Cheney, K.M., Stampfer, M.R., Dwivedi, P.P., et al. (2006). ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription. Mol. Cancer Res., 4, 655-665..
33. Wong, I.H., Lo, Y.D., Zhang, J., Liew, C.T., Ng, M.H., Wong, N., Lai, P.B., Lau, W.Y., Hjelm, N.M. and Johnson, P.J. (1999). Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res., 59, 71-73.
34. Tao, R., Li, J., Xin, J., Wu, J., Guo, J., Zhang, L., Jiang, L., Zhang, W., Yang, Z. and Li, L. (2011). Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. PLoS One, 6, e19862.
35. Song, M.A., Tiirikainen, M., Kwee, S., Okimoto, G., Yu, H. and Wong, L.L. (2013). Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One, 8, e55761.
36. Shen, J., Wang, S., Zhang, Y.J., Kappil, M., Wu, H.C., Kibriya, M.G., Wang, Q., Jasmine, F., Ahsan, H., Lee, P.H., et al. (2012). Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology, 55, 1799-1808.
37. Lee, H.C., Kim, M. and Wands, J.R. (2006). Wnt/Frizzled signaling in hepatocellular carcinoma. Front. Biosci., 11, 1901-1915.
38. Saitta, C., Tripodi, G., Barbera, A., Bertuccio, A., Smedile, A., Ciancio, A., Raffa, G., Sangiovanni, A., Navarra, G., Raimondo, G. et al. (2015). Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. Liver Int. 35, 2311-2317.
39. Liu, S., Cheng, J., Zhang, X., Jiang, S., Liu, X., Li, M., Zhang, J., Li, X., Xu, C., Chen, X., et al. (2013). Quantificational methylation analysis of APC and AXIN2 in HBV-related hepatocellular carcinoma. Curr. Cancer Ther. Rev., 9, 137-146.
40. Zender, L., Villanueva, A., Tovar, V., Sia, D., Chiang, D.Y. and Llovet, J.M. (2010). Cancer gene discovery in hepatocellular carcinoma. J. Hepatol., 52, 921-929.
41. Lee, H.S., Kim, B.H., Cho, N.Y., Yoo, E.J., Choi, M., Shin, S.H., Jang, J.J., Suh, K.S., Kim, Y.S. and Kang, G.H. (2009). Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin. Cancer Res., 15, 812-820.
42. Kittaka, N., Takemasa, I., Takeda, Y., Marubashi, S., Nagano, H., Umeshita, K., Dono, K., Matsubarak, K., Matsuura, N. and Monden, M. (2008). Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur. J. Cancer, 44, 885-897.
43. Hernandez-Vargas, H., Lambert, M.P., Le Calvez-Kelm, F., Gouysse, G., McKay-Chopin, S., Tavtigian, S.V., Scoazec, J.Y. and Herceg, Z. (2010). Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One, 5, e9749.
44. Dunwell, T., Hesson, L., Rauch, T.A., Wang, L., Clark, R.E., Dallol, A., Gentle, D., Catchpoole, D., Eamonn, R., Pfeifer, G.P., et al. (2010). A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol. Cancer, 9, 44-56.
45. Vincent, A., Omura, N., Hong, S.M., Jaffe, A., Eshleman, J.R. and Goggins, M. (2011). Genome-wide analysis of promoter methylation associated with gene expression profiles of pancreatic adenocarcinomas. Clin. Cancer Res., 17, 4341-4354.
46. Yamashita, S., Tsujino, Y., Moriguchi, K., Tatematsu, M. and Ushijima, T. (2006). Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci., 97, 64-71.
47. Vincent, A., Omura, N., Hong, S.M., Jaffe, A., Eshleman, J.R. and Goggins, M. (2011). Genome-wide analysis of promoter methylation associated with gene expression profiles of pancreatic adenocarcinomas. Clin. Cancer Res., 17, 4341-4354.
48. Leclerc, D., Levesque, N., Cao, Y., Deng, L., Wu, Q., Powell, J., Sapienza, C. and Rozen, R. (2013). Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients. Cancer Prev. Res., 6, 1171-1181.
49. Mayol, G., Martin-Subero, J.I., Rios, J., Queiros, A., Kulis, M., Sunol, M., Esteller, M., Gomez, S., Garcia, I., Torres, C.D., et al. (2012). DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS One, 7, e48401.
50. Furuta, M., Kozaki, K.I., Tanaka, S., Arii, S., Imoto, I. and Inazawa, J. (2009). miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis, 31, 766-776.
51. Birts, C.N., Harding, R., Soosaipillai, G., Halder, T., Azim-Araghi, A., Darley, M., Cutress, R., Bateman, A.C. and Blaydes, J.P. (2011). Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance. Biol. Cell, 103, 1-19.
52. Zhang, H.H., Zhang, Z.Y., Che, C.L., Mei, Y.F. and Shi, Y.Z. (2013). Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines. Int. J. Clin. Exp. Pathol., 6, 1734.
53. Tam, C.W., Cheng, A.S., Ma, R.Y.M., Yao, K.M. and Shiu, S.Y.W. (2006). Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor. Endocrinology, 147, 5023-5033.
54. Landi, D., Gemignani, F., Pardini, B., Naccarati, A., Garritano, S., Vodicka, P., Vodickova, L., Canzian, F., Novotny, J., Barale, R., et al. (2012). Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. Cancer, 118, 4670-4680.
55. Than, B.L.N., Goos, J.A.C.M., Sarver, A.L., O'Sullivan, M.G., Rod, A., Starr, T.K., Fijneman, R.J., Zhao, L., Zhang, Y., Largaespade, D.A. et al. (2014). The role of KCNQ1 in mouse and human gastrointestinal cancers. Oncogene, 33, 3861-3868.
56. Salyer, S.A., Olberding, J.R., Distler, A.A., Lederer, E.D., Clark, B.J., Delamere, N.A. and Khundmiri, S.J. (2013). Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 1832, 1734-1743.
57. Blaveri, E., Brewer, J.L., Roydasgupta, R., Fridlyand, J., DeVries, S., Koppie, T., Pajavar, S., Mehta, K., Carroll, P., Simko, J.P., et al. (2005). Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin. Cancer Res., 11, 7012-7022.
58. Keita, M., Wang, Z.Q., Pelletier, J.F., Bachvarova, M., Plante, M., Gregoire, J., Renaud, M.C., Mes-Masson, A.M., Paquet, E.R. and Bachvarov, D. (2013) Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression. Gynecol. Oncol., 128, 356-363.
59. Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimur, L., Kikkawa, N., Seki, N. and Nakagawa, M. (2010). miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer, 102, 883-891.
60. Luedi, P.P., Dietrich, F.S., Weidman, J.R., Bosko, J.M., Jirtle, R.L. and Hartemink, A.J. (2007). Computational and experimental identification of novel human imprinted genes. Genome Res., 17, 1723-1730.
61. Xie, C., Jiang, X.H., Zhang, J.T., Sun, T.T., Dong, J.D., Sanders, A.J., Diao, R.Y., Wang, Y., Fok, K.L., Tsang, L.L., et al. (2013). CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene, 32, 2282-2291.
62. Yeh, K.T., Chen, T.H., Yang, H.W., Chou, J.L., Chen, L.Y., Yeh, C.M., Chen, Y.H., Lin, R.I., Su, H.Y., Chen, G.C.W., et al. (2011). Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer. Epigenetics, 6, 727-739.
63. Rozier, L., El-Achkar, E., Apiou, F. and Debatisse, M. (2004). Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene, 23, 6872-6880.
64. House, C.D., Vaske, C.J., Schwartz, A.M., Obias, V., Frank, B., Luu, T., Sarvazyan, N., Irby, R., Strausberg, R.L., Hales, T.G., et al. (2010). Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res., 70, 6957-6967.
65. Teschendorff, A.E. and Widschwendter, M. (2012). Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics, 28, 1487-1494.
66. Teschendorff, A.E., Liu, X., Caren, H., Pollard, S.M., Beck, S., Widschwendter, M. and Chen, L. (2014). The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput. Biol., 10, e1003709.
67. Zhang, N., Wu, H.J., Zhang, W., Wang, J., Wu, H. and Zheng, X. (2015). Predicting tumor purity from methylation microarray data. Bioinformatics, btv370.